Variability in activity of hepatic CYP3A4 in patients infected with HIV.
about
Drug-drug interactions between anti-retroviral therapies and drugs of abuse in HIV systemsVariability in drug metabolizing enzyme activity in HIV-infected patients.Virtual inhibitory quotient predicts response to ritonavir boosting of indinavir-based therapy in human immunodeficiency virus-infected patients with ongoing viremia.Lack of sex-related differences in saquinavir pharmacokinetics in an HIV-seronegative cohort.Effect of widely used combinations of antiretroviral therapy on liver CYP3A4 activity in HIV-infected patients.Minimal effect of MDR1 and CYP3A5 genetic polymorphisms on the pharmacokinetics of indinavir in HIV-infected patientsSexual risk behaviors and substance use among alcohol abusing HIV-positive men who have sex with men.Therapeutic drug monitoring and human immunodeficiency virus (HIV) antiretroviral therapy.Possible drug-metabolism interactions of medicinal herbs with antiretroviral agents.The impact of cytokines on the expression of drug transporters, cytochrome P450 enzymes and chemokine receptors in human PBMC.Alcohol's role in HIV transmission and disease progression.Pharmacokinetics of indinavir and ritonavir administered at 667 and 100 milligrams, respectively, every 12 hours compared with indinavir administered at 800 milligrams every 8 hours in human immunodeficiency virus-infected patients.The role of cytokines in the regulation of drug disposition: extended functional pleiotropism?Lack of in vivo correlation between indinavir and saquinavir exposure and cytochrome P450 3A phenotype as assessed with oral midazolam as a phenotype probe.
P2860
Q26851241-030DF46D-52A4-467D-99E9-B96FAF5CF127Q33791508-4FF690EA-37F6-49C3-B41B-04DD4E77A516Q34253139-14799B26-57F5-4DE2-89C5-D570C0AE41DFQ35827510-2AB8BCD2-8D0D-4179-9DF0-D48960BA4C10Q35827661-ABF523FC-9214-4D45-A93D-7D2B49B91403Q36024688-59057A88-7E91-4184-8726-81B46C926CB4Q36088295-1764924F-7757-4C7C-AC8A-3490BCA9891CQ36376533-92CB8D71-38A1-4EAD-B347-6ADE17C3E486Q36551135-C18F8054-D536-42C6-99BF-28A2B0A99A65Q37230649-3CACDE72-A804-4686-A049-7B0662114324Q37386658-D23F5C9E-A824-4707-84AB-F014D92F9F0DQ37598680-D4EFB7C4-AB6B-48E9-A45A-B9990D168C85Q37836908-3280E9E6-E2C3-4AAA-B18F-9964E8DA2898Q46174011-95CAEC86-908E-4134-9861-588DF932283B
P2860
Variability in activity of hepatic CYP3A4 in patients infected with HIV.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
Variability in activity of hepatic CYP3A4 in patients infected with HIV.
@en
Variability in activity of hepatic CYP3A4 in patients infected with HIV.
@nl
type
label
Variability in activity of hepatic CYP3A4 in patients infected with HIV.
@en
Variability in activity of hepatic CYP3A4 in patients infected with HIV.
@nl
prefLabel
Variability in activity of hepatic CYP3A4 in patients infected with HIV.
@en
Variability in activity of hepatic CYP3A4 in patients infected with HIV.
@nl
P2093
P2860
P1433
P1476
Variability in activity of hepatic CYP3A4 in patients infected with HIV.
@en
P2093
P2860
P304
P356
10.1592/PHCO.20.11.898.35262
P407
P577
2000-08-01T00:00:00Z